Patents by Inventor W. Shawn Carbonell

W. Shawn Carbonell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-INTEGRIN BETA-1 ANTIBODY COMPOSITIONS AND METHODS OF USE THEREOF
    Publication number: 20220089744
    Abstract: The current invention provides human variable chain framework regions and humanized antibodies comprising the framework regions, the antibodies being specific for integrin ?1. The invention also provides methods for utilizing the antibodies, for example to treat diseases such as cancer.
    Type: Application
    Filed: October 7, 2021
    Publication date: March 24, 2022
    Inventor: W. Shawn Carbonell
  • Anti-integrin ?1 antibody compositions and methods of use thereof
    Patent number: 11142576
    Abstract: The current invention provides human variable chain framework regions and humanized antibodies comprising the framework regions, the antibodies being specific for integrin ?1. The invention also provides methods for utilizing the antibodies, for example to treat diseases such as cancer.
    Type: Grant
    Filed: July 12, 2018
    Date of Patent: October 12, 2021
    Assignee: Oncosynergy, Inc.
    Inventor: W. Shawn Carbonell
  • ANTI-INTEGRIN BETA-1 ANTIBODY COMPOSITIONS AND METHODS OF USE THEREOF
    Publication number: 20180312591
    Abstract: The current invention provides human variable chain framework regions and humanized antibodies comprising the framework regions, the antibodies being specific for integrin ?1. The invention also provides methods for utilizing the antibodies, for example to treat diseases such as cancer.
    Type: Application
    Filed: July 12, 2018
    Publication date: November 1, 2018
    Inventor: W. Shawn Carbonell
  • Anti-integrin ?1 antibody compositions and methods of use thereof
    Patent number: 10023638
    Abstract: The current invention provides human variable chain framework regions and humanized antibodies comprising the framework regions, the antibodies being specific for integrin ?1. The invention also provides methods for utilizing the antibodies, for example to treat diseases such as cancer.
    Type: Grant
    Filed: December 24, 2013
    Date of Patent: July 17, 2018
    Assignee: Oncosynergy, Inc.
    Inventor: W. Shawn Carbonell
  • ANTI-INTEGRIN BETA-1 ANTIBODY COMPOSITIONS AND METHODS OF USE THEREOF
    Publication number: 20140328830
    Abstract: The current invention provides human variable chain framework regions and humanized antibodies comprising the framework regions, the antibodies being specific for integrin ?1. The invention also provides methods for utilizing the antibodies, for example to treat diseases such as cancer.
    Type: Application
    Filed: December 24, 2013
    Publication date: November 6, 2014
    Applicant: ONCOSYNERGY, INC.
    Inventor: W. Shawn Carbonell